Takamura, Saori <br/><br/>
Effects of tumor necrosis factor-α, interleukin-23 and interleukin-17A inhibitors on bodyweight and body mass index in patients with psoriasis.  [electronic resource] 

 -  The Journal of dermatology  Sep 2018 
 - 1130-1134 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1346-8138 
<br/><br/><label>Standard No.: </label>10.1111/1346-8138.14526  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Biological Products--pharmacology<br/>Body Mass Index<br/>Body Weight--drug effects<br/>Dermatologic Agents--pharmacology<br/>Female<br/>Humans<br/>Infliximab--pharmacology<br/>Interleukin-17--antagonists & inhibitors<br/>Interleukin-23 Subunit p19--antagonists & inhibitors<br/>Male<br/>Middle Aged<br/>Psoriasis--drug therapy<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Ustekinumab--pharmacology